NCT03564782
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Early Phase 1
Drug Category: Immunotherapy
Key Eligibility Criteria:
Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes:
Exclusions: Patients with known active central nervous system metastases and/or carcinomatous meningitis
https://ClinicalTrials.gov/show/NCT03564782